SYSTEMIC SCLEROSIS WITH LUNG INVOLVEMENT

Clinical trials for SYSTEMIC SCLEROSIS WITH LUNG INVOLVEMENT explained in plain language.

Never miss a new study

Get alerted when new SYSTEMIC SCLEROSIS WITH LUNG INVOLVEMENT trials appear

Sign up with your email to follow new studies for SYSTEMIC SCLEROSIS WITH LUNG INVOLVEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Drug trial aims to put the brakes on scarred lungs

Disease control Terminated

This study tested whether an investigational drug called vixarelimab could slow the decline in lung function for people with two types of progressive lung scarring diseases. About 286 adults with either idiopathic pulmonary fibrosis or lung disease related to systemic sclerosis (…

Matched conditions: SYSTEMIC SCLEROSIS WITH LUNG INVOLVEMENT

Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

SYSTEMIC SCLEROSIS WITH LUNG INVOLVEMENT

Get alerted when new SYSTEMIC SCLEROSIS WITH LUNG INVOLVEMENT trials appear

Drug trial aims to put the brakes on scarred lungs